Cidara prices upsized $350M public offering of common stock at $44.00 per share

Cidara Therapeutics, Inc.

Upsized offering from $250M to gross proceeds of $350M (7,954,546 shares at $44.00/share).
Underwriters granted 30-day option to purchase up to 1,193,181 additional shares.
Joint book-runners: J.P. Morgan, Morgan Stanley, Guggenheim Securities, Cantor Fitzgerald.
Offering expected to close June 26, 2025, subject to customary closing conditions.
Proceeds intended for general corporate purposes; no specific use disclosed.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.